(Q33233776)

English

Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 July 2017

Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies (English)

1 reference

Europe PubMed Central

24 July 2017

1 reference

based on heuristic

inferred from title

7

object named as

Jerome Kim

1 reference

Europe PubMed Central

24 July 2017

Barney S. Graham

14

object named as

Barney S Graham

1 reference

Europe PubMed Central

24 July 2017

author name string

Surender Khurana

1

1 reference

Europe PubMed Central

24 July 2017

James Needham

2

1 reference

Europe PubMed Central

24 July 2017

Bonnie Mathieson

3

1 reference

Europe PubMed Central

24 July 2017

Isaac R Rodriguez-Chavez

4

1 reference

Europe PubMed Central

24 July 2017

Andrew T Catanzaro

5

1 reference

Europe PubMed Central

24 July 2017

Robert T Bailer

6

1 reference

Europe PubMed Central

24 July 2017

Vicky Polonis

8

1 reference

Europe PubMed Central

24 July 2017

David A Cooper

9

1 reference

Europe PubMed Central

24 July 2017

Jan Guerin

10

1 reference

Europe PubMed Central

24 July 2017

Michael L Peterson

11

1 reference

Europe PubMed Central

24 July 2017

Marc Gurwith

12

1 reference

Europe PubMed Central

24 July 2017

Nga Nguyen

13

1 reference

Europe PubMed Central

24 July 2017

Hana Golding

15

1 reference

Europe PubMed Central

24 July 2017

publication date

1 March 2006

1 reference

Europe PubMed Central

24 July 2017

Journal of Virology

1 reference

Europe PubMed Central

24 July 2017

80

1 reference

Europe PubMed Central

24 July 2017

5

1 reference

Europe PubMed Central

24 July 2017

2092-2099

1 reference

Europe PubMed Central

24 July 2017

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1395407

21 June 2018

Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1395407

21 June 2018

Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1395407

21 June 2018

Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1395407

21 June 2018

Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1395407

21 June 2018

Utility of various commercially available human immunodeficiency virus (HIV) antibody diagnostic kits for use in conjunction with efficacy trials of HIV-1 vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1395407

21 June 2018

Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1395407

31 October 2018

Trial-related discrimination in HIV vaccine clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1395407

31 October 2018

Interest among gay/bisexual men in greater Boston in participating in clinical trials of preventive HIV vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1395407

31 October 2018

Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/16474117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160

1 reference

https://pubmed.ncbi.nlm.nih.gov/16474117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lessons from failure--preparing for future HIV-1 vaccine efficacy trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/16474117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpreting HIV serodiagnostic test results in the 1990s: social risks of HIV vaccine studies in uninfected volunteers. NIAID AIDS Vaccine Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16474117

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JVI.80.5.2092-2099.2006

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33233776&oldid=1961351596"